Turn Therapeutics (TTRX) Assets (2024 - 2026)

Turn Therapeutics (TTRX) posted quarterly Assets of $18.6 million for Q1 2026, up 53.3% quarter-over-quarter from $12.2 million in Q4 2025.

Turn Therapeutics (TTRX) Assets (2024 - 2026) Analysis & Trends

Turn Therapeutics' Assets history runs 3 years deep, the most recent figure standing at $18.6 million for Q1 2026.

In Q1 2026, Assets changed N/A year-over-year to $18.6 million; the TTM figure through Mar 2026 stood at $18.6 million (changed N/A YoY), while the FY2025 annual figure was $12.2 million, up 493.6% from the prior year.
Assets for Q1 2026 stood at $18.6 million, up from $12.2 million in the prior quarter.
The five-year high for Assets was $18.6 million in Q1 2026, with the low at $2.0 million in Q4 2024.
The 3-year median for Assets is $8.2 million (2025), against an average of $9.3 million.
Peak annual rise in Assets reached 493.6% in 2025, while the deepest fall reached 493.6% in 2025.
Turn Therapeutics' Assets stood at $2.0 million in 2024, then soared by 493.6% to $12.2 million in 2025, then soared by 53.3% to $18.6 million in 2026.
Business Quant data shows TTRX's Assets at $18.6 million in Q1 2026, $12.2 million in Q4 2025, and $4.3 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Assets (Qtr)
1	Vertex Pharmaceuticals	128.13 Bn	120.28 Bn	2.84 Bn	27.42 Bn
2	Regeneron Pharmaceuticals	112.33 Bn	104.33 Bn	3.93 Bn	41.73 Bn
3	Argenx Se	53.24 Bn	48.05 Bn	1.41 Bn	10.03 Bn
4	Revolution Medicines	43.64 Bn	43.64 Bn	-	4.32 Bn
5	BeOne Medicines	39.27 Bn	34.17 Bn	1.53 Bn	9.18 Bn
6	MindWalk Holdings	35.32 Bn	35.31 Bn	1.82 Bn	15.59 Mn
7	Royalty Pharma	33.72 Bn	35.84 Bn	-	19.82 Bn
8	Alnylam Pharmaceuticals	30.58 Bn	27.27 Bn	992.69 Mn	5.56 Bn
9	Insmed	27.01 Bn	25.85 Bn	358.27 Mn	2.10 Bn
10	Turn Therapeutics	285.07 Mn	285.07 Mn	-	16.96 Mn

Download Data